[1]谢蔚,金杭美.女性尿失禁的分类及发病机制[J].实用妇产科杂志,2009, 25（11）：642-643.
[2] SteelA C, Kohli N,Mallipeddi P,et al.Pharmacologic causes of female incontinence [J]. International Urogynecology Journal,1999,
10:106-110.
[3] Tsakiris P, Oelke M, MichelM C.Drug-induced urinary inconti-nence[J].Drugs Aging,2008, 25:541-549.
[4]罗文丰.沙利度胺相关急迫性尿失禁[J].药物不良反应杂志,2009,11:370-371.
[5]杨清明,苏琴.乐沙定毒副作用的临床特点和预防处理[J].中国康复理论与实践,2004, 10(2): 81-83.
[6] ELOXATIN? Prescribing Information (oxaliplatin for injection) Distributed by Sanofi-Synthelabo Inc[EB/OL].[2010-03-02].http:// products.sanofi-aventis.us/eloxatin/eloxtin.html.
[7] Arafat T, Patricia H, Stefan M, et al. Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors[J]. Journal of Neuro-Oncology,1999, 42:73-77. |
